Pulmonary Fibrosis

"Pulmonary Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Descriptor ID	D011658
MeSH Number(s)	C08.381.765
Concept/Terms	Pulmonary Fibrosis Pulmonary Fibrosis Pulmonary Fibroses Fibroses, Pulmonary Fibrosis, Pulmonary Alveolitis, Fibrosing Alveolitis, Fibrosing Alveolitides, Fibrosing Fibrosing Alveolitides Fibrosing Alveolitis Hamman-Rich Syndrome Hamman Rich Syndrome Syndrome, Hamman-Rich

Below are MeSH descriptors whose meaning is more general than "Pulmonary Fibrosis".

Diseases [C]
Respiratory Tract Diseases [C08]
Lung Diseases [C08.381]
Pulmonary Fibrosis [C08.381.765]

Below are MeSH descriptors whose meaning is more specific than "Pulmonary Fibrosis".

Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pulmonary Fibrosis" by people in this website by year, and whether "Pulmonary Fibrosis" was a major or minor topic of these publications.

Bar chart showing 27 publications over 17 distinct years, with a maximum of 6 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2004	1	0	1
2007	0	1	1
2009	0	1	1
2011	1	0	1
2012	1	0	1
2013	1	0	1
2016	1	0	1
2017	2	0	2
2019	1	1	2
2020	0	2	2
2021	1	0	1
2022	2	0	2
2023	2	0	2
2024	3	3	6
2025	1	0	1
2026	1	0	1

Below are the most recent publications written about "Pulmonary Fibrosis" by people in Profiles.

Arif M, Basu A, Zuo BLG, Zuo MXG, O'Brien KJ, Pommerolle L, Caro-Rivera LM, De Jesus-Rojas W, Ramos-Benitez MJ, Behan M, Introne WJ, Frost G, Moaddel R, Gahl WA, Malicdan MCV, Gochuico BR, Cinar R. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2026 Jan 01; 74(1):80-93.

View in: PubMed
Lee HJ, Lee NK, Kim J, Kim J, Seo D, Shin HE, Kim J, Ahn JH, Kim SN, Kim HS, Park J, Park W, Hong KS, Park CG, Lee W. Sequential nanoparticle therapy targeting neutrophil hyperactivation to prevent neutrophil-induced pulmonary fibrosis. J Nanobiotechnology. 2025 May 26; 23(1):381.

View in: PubMed
Magdaleno C, Tschumperlin DJ, Rajasekaran N, Varadaraj A. SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis. Sci Rep. 2024 12 30; 14(1):31855.

View in: PubMed
De Jes?s-Rojas W, Reyes-Pe?a L, Mu?iz-Hernandez J, Mena-Ventura R, Camareno-Soto G, Rosario-Ortiz G, Ramos-Benitez MJ, Egozcue-Dionisi M, Rivera-Jimenez E, Rom?n-Carlo R. Application of Forced Oscillation Technique in Assessing Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. Adv Respir Med. 2024 Oct 24; 92(6):444-451.

View in: PubMed
Okabe Y, Toda E, Urushiyama H, Terashima Y, Kunugi S, Kajimoto Y, Terasaki M, Matsushima K, Saito A, Yamauchi Y, Nagase T, Shimizu A, Terasaki Y. Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration. Sci Rep. 2024 10 10; 14(1):23653.

View in: PubMed
Giannakopoulos S, Park J, Pak J, Tallquist MD, Verma S. Post-COVID pulmonary injury in K18-hACE2 mice shows persistent neutrophils and neutrophil extracellular trap formation. Immun Inflamm Dis. 2024 08; 12(8):e1343.

View in: PubMed
Diwan R, Bhatt HN, Dong R, Estevao IL, Varela-Ramirez A, Nurunnabi M. Cell selective BCL-2 inhibition enabled by lipid nanoparticles alleviates lung fibrosis. J Control Release. 2024 Jun; 370:421-437.

View in: PubMed
Yoon H, Dean LS, Jiyarom B, Khadka VS, Deng Y, Nerurkar VR, Chow DC, Shikuma CM, Devendra G, Koh Y, Park J. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms. Front Immunol. 2023; 14:1268510.

View in: PubMed
Diwan R, Bhatt HN, Beaven E, Nurunnabi M. Emerging delivery approaches for targeted pulmonary fibrosis treatment. Adv Drug Deliv Rev. 2024 01; 204:115147.

View in: PubMed
Knipe RS, Nurunnabi M, Probst CK, Spinney JJ, Abe E, Bose RJC, Ha K, Logue A, Nguyen T, Servis R, Drummond M, Haring A, Brazee PL, Medoff BD, McCarthy JR. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2023 02 01; 324(2):L190-L198.

View in: PubMed

People

Explore

Similar Concepts

Top Journals